Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VET1450
| Cat. No. | VET1450 |
| Background | pCDNA3.1(+) is a 5.4 kb vector derived from pCDNA3 designed for high-level stable and transient expression in mammalian hosts. Most mammalian cells are capable of high levels of stable and non-replicative transient expression. Human cytomegalovirus immediate early (CMV) promoter for high-level expression in a wide range of mammalian cells. Multiple cloning sites in forward (+) and reverse (-) directions to facilitate cloning of neomycin resistance genes for selection of stable cell lines. Aberrant replication in cell lines latently infected with SV40 or expressing the SV40 large T antigen (e.g., COS-1, COS-7). |
| Host Cell | Mammalian cells, Escherichia coli |
| Promoter | CMV |
| Resistance | Ampicillin |
| Selection | Neomycin |
| Vector Type | Expression Vector |
| Vector Size | 5428 bp |
The pcDNA3.1(+) plasmid is a widely used expression vector in molecular biology and genetic engineering research. Its numerous applications include:
1. Cloning and expression of target genes: pcDNA3.1(+) enables the cloning of target genes of interest into the multiple cloning site (MCS) within the plasmid. The inserted gene can be expressed under the control of a strong constitutive promoter, such as the cytomegalovirus (CMV) promoter, allowing researchers to produce large amounts of the protein encoded by the gene.
2. Gene overexpression studies: By expressing a gene of interest using pcDNA3.1(+), researchers can study the effects of gene overexpression on cellular processes, pathways, or phenotypes.
3. Construction of reporter gene vectors: pcDNA3.1(+) can be used to construct reporter gene vectors for monitoring gene expression or protein function.
4. Vaccine and therapeutic protein production: The pcDNA3.1(+) vector can be used for the production of recombinant proteins, including vaccines or therapeutic proteins. It offers a system for the large-scale production of proteins, allowing for potential use in biopharmaceutical applications.
A: Although not required, if you want to linearize the pcDNA3.1 vector before stable transfection, Pvu I or Sca I are single-cutting enzymes that cut within the ampicillin resistance gene and should work well.
A: They are derived from pcDNA3 vector.
A: It can carry out high-level stable and non-replicative transient expression in most mammalian cells.
A: The pcDNA3.1 vector contains the core CMV promoter that is truncated before the initiation of transcription, while the pcDNA 3.3-TOPO vector contains 672 bp of the native CMV promoter.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
pcDNA3.1(+) enables high-level expression in a wide range of mammalian cells. This has greatly enhanced the overall value of our research.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.